Arteriovenous Decompression for Branch Retinal Vein Occlusion with Internal Membrane Peeling for Macular Edema
Authors:
V. Krásnik; P. Strmeň; J. Štefaničková; P. Krajčová
Authors‘ workplace:
Klinika oftalmológie LF UK, Bratislava, prednosta prof. MUDr. Peter Strmeň, CSc.
Published in:
Čes. a slov. Oftal., 64, 2008, No. 2, p. 57-61
Overview
Purpose:
A retrospective study of anatomical and functional results of microsurgical therapy of branch retinal vein occlusion with internal limiting membrane peeling due to macular edema.
Materials and methods:
Eleven patients (5 men and 6 women), mean age 59.18 years (34-74 years) who underwent the surgery at the Department of Ophthalmology, Comenius University in Bratislava, Slovak Republic, from June 1st, 2000 to May 31st, 2006, were enrolled in the study.
The follow-up period ranged from 14 to 72 months (average 28.5 months). The patients were indicated to the arterio-venous decompression with internal retinal membrane peeling due to the macular edema after the fluorescein angiography. Patients with rubeosis of the iris were excluded from further evaluation and their initial best corrected visual acuity was 0,3 and less. A complete eye examination (best corrected visual acuity, intraocular pressure, fluorescein angiography, slit lamp examination of both the anterior and posterior eye segments) was performed in each patient before the surgery, and every 3-4 months during the first year and every 6-9 months during following years. Fluorescein angiography was used to evaluate anatomic results 3 months after the surgery. As positive signs were considered: the blood flow improvement peripherally to the arteriovenous decompression site, the vessel dilatation, and the reduction of the hyperfluorescence and the macular edema reduction. To analyze the functional results, the best corrected visual acuity changes before and after surgery were used.
Results:
Positive anatomic changes were in 8 (72,73%) patients; in 1 patient the area of non-perfusion expanded, and 2 patients were presented with stable anatomic findings. The best corrected visual acuity averaged 0.16 (± 0.1070) before the surgery, 0.2909 (± 0.2264) 3 months after the surgery, and 0.3818 (± 0.3178) at the time of the last examination. Significant differences between the visual acuity before and 3 months after surgery were confirmed by Student’s T-test. The visual acuity measured at the time of the last measurement improved by +2 and more lines in 6 patients, reminded unchanged in 4 patients, and worsened by –2 or more lines in 1 patient.
Conclusion:
Microsurgical treatment of branch retinal vein occlusion expands the therapeutic armamentarium used to manage this severe disease. In case the partial occlusion is present, arteriovenous decompression has a positive effect on the final anatomic and functional results.
Key words:
branch retinal vein occlusion, arteriovenous decompression, internal limiting membrane peeling
Sources
1. Branch vein occlusion study group: Argon laser photocoagulation for macular edema in branch retinal vein occlusion. Am. J. Ophthalmol., 98, 1984: 271–282.
2. Branch vein occlusion study group: Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous haemorrhage in branch vein occlusion. Arch. Ophthalmol., 104, 1986: 34–41.
3. Dillinger, P., Mester, U.: Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema. Graefeęs Arch. Clin. Exp. Ophthalmol., 242, 2004: 630–637.
4. Dotřelová, D., Dubská, Z., Kuthan, P. et al.: První zkušenosti s chirurgickou dekompresí žíly u větvové retinální okluze. Čes. a slov. Oftal., 57, 2001: 359–366.
5. Feist, R.M., Ticho, B.M., Shapiro, M.J., et al.: Branch retinal vein occlusion and quadratic variation in arteriovenous crossing. Am. J. Ophthalmol., 113, 1992: 664–668.
6. Finkelstein, D., Kumball, A.: Risk factors of branch retinal vein occlusion. Arch. Ophthalmol., 104, 1986: 795.
7. Fišer, I., Handlová, R., Bedřich, P. et al.: Peeling MLI v léčbě chorob vitreomakulárního rozhraní. 8. Vejdovského olomoucký vědecký den, 24. 3. 2007, Abstrakta: 38–42.
8. Garcia-Arumi, J., Martinez-Castillo, V., Bioxadera, A. et al.: Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina, 24, 2004: 530–540.
9. Gandorfer, A., Messmer, E.M., Ulbig , M.W. et al.: Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina, 20, 2000: 126–133.
10. Joffe, L., Goldberg, R.E., Magargal, L.E. et al.: Macular branch vein occlusion. Ophthalmology, 87, 1980: 91–98.
11. Heier, J. S., Morley, M.G.: Venous obstructive disease of the retina. Chapter 18, 18.1.–18.8. v: Yanoff, M., Duker, J.S.: Ophthalmology, Mosby, London, 1999, 1616 p.
12. Klein, R., Klein, B.E., Moss, S.E. et al.: The epidemiology of retinal vein occlusion: the Beaver Dam eye study. Trans. Am. Ophthalmol., 98, 2000: 133–140.
13. Kube, T., Feltgen, N., Pache, M. et al.: Angiographic findings in arteriovenous dissection (sheathotomy) for decompression of branch retinal vein occlusion. Graefeęs Arch. Clin. Exp. Ophthalmol., 243, 2005: 334–338.
14. Mitchell, P., Smith, W., Chang, A.: Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains eye study. Arch. Ophthalmol., 114, 1996: 1243–1247.
15. Opremcak, E.M., Bruce, R.A.: Surgical decompression of branch retinal vein occlusion via arterivenous crossing sheathotomy. Retina, 19, 1999: 1–5.
16. Osterloh, M.D., Charles, S.: Surgical decompression of branch retinal vein occlusion. Arch. Ophthalmol. 106, 1988: 1469–1471.
17. Recchia, F.M., Ruby, A.J., Carvalho Recchia C.A.: Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am. J. Ophthalmol., 139, 2005: 447–454.
18. Shah, G.K.: Adventitial sheathotomy for treatment of macular edema associated with branch retinal vein occlusion. Current Opinion in Ophthalmology, 11, 2000: 171–174.
19. Staurenghi, G., Lonati, Ch., Aschero, M. et al.: Arteriovenous crossing as a risk factor in branch retinal vein occlusion. Am. J. Ophthalmol., 117, 1994: 211–213.
20. Stolba, U., Binder, S., Gruber, D. et al.: Vitrectomy for persistent diffuse diabetic macular edema. Am. J. Ophthalmol., 140, 2005: 295–301.
21. The eye disease case-control study group: Risk factor for branch retinal vein occlusion. Am. J. Ophthalmol., 116, 1993: 286–296.
22. The eye disease case-control study group (II): Arteriovenous crossing patterns in branch retinal vein occlusion. Ophthalmology, 100, 1993: 423–428.
23. Weinberg, D.: Arteriovenous crossing as a risk factor in branch retinal vein occlusion. Am. J. Ophthalmol. 118, 1994: 263–265.
24. Weinberg, D., Dodwell, D.G., Fern, S.A.: Anatomy of arteriovenous crossing in branch retinal vein occlusion. Am. J. Ophthalmol., 109, 1990: 298–302.
25. Yamaji, H., Shiraga, F., Tsuchida, Y. et al.: Evaluation of arteriovenous crossing sheathotomy for branch retinal vein occlusion by fluorescein videoangiography and image analysis. Am. J. Ophthalmol. 137, 2004: 834–841.
Labels
OphthalmologyArticle was published in
Czech and Slovak Ophthalmology
2008 Issue 2
Most read in this issue
- The Application of the Autologous Serum Eye Drops Results in Significant Improvement of the Conjunctival Status in Patients with the Dry Eye Syndrome
- Treatment for Recurrent Pterygium
- Spontaneous Premacular Hemorrhage
- Applying the DNA Diagnostics in Patients with Superficial Keratitis of Viral Origin